AVIRAtea Pharmaceuticals
+2.1% today · +32.6% over a year
No score: too little data.
Quality: among the weakest. No dividend.
Atea Pharmaceuticals (AVIR) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €309.6M. Over the past 12 months the price changed by +32.6%, with an annualised volatility of 53% and a largest fall of 34%.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Share issuance (1 y)supports the score · better than 90% of peers
- Change in cash flow / assets (5 y)weighs on the score · better than 1% of peers
- EBIT / EVweighs on the score · better than 2% of peers
Red flags and notes
No red flagsNone of our published warning rules is triggered right now.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/B
- 1.7
- Market cap (EUR)
- €309.6M
Profitability and debt
- Return on equity
- −58.1%
- Return on invested capital
- −90.8%
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- +2.1%
- 1 month
- −15.0%
- 1 year
- +32.6%
- Volatility, 1 yr
- 52.7%
- Max drawdown, 1 yr
- −34.3%
- Beta
- 0.74
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| ALECAlector | 1/10 | 0.0% | 76.2% |
|---|---|---|---|
| EMBCEmbecta | 3/10 | 5.2% | −52.5% |
| ALLOAllogene Therapeutics Inc | —/10 | 0.0% | −1.0% |
| OFIXOrthofix Medical Inc | 1/10 | 0.0% | −46.4% |
| ENTAEnanta Pharmaceuticals Inc | —/10 | 0.0% | 1.9% |
| EBSEmergent BioSolutions Inc | 1/10 | 0.0% | −41.0% |
| EDITEditas Medicine Inc | 1/10 | 0.0% | −4.5% |
| ARCTArcturus Therapeutics Holdings | 1/10 | 0.0% | 24.8% |
News and filings
- Atea Pharmaceuticals, Inc.: 10-Q — Quarterly report for the period ending 30 Jun 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 13 Aug 2026
- Atea Pharmaceuticals, Inc.: 8-K — Results of operations
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 13 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
No published ratings in the last 12 months.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.